How Many States Have a Black Market IUD Problem? Interchange 2014
Since 2009, 7 states have experienced incidents where women have been implanted with black market IUDs. 39 doctors have been prosecuted and over 450 patients in Texas alone have been implanted with black market IUDs.
Learn the scope of the problem in the United States in SAFEMEDICINES’ report Black Market IUD Cases 2009-2013.
7:30 a.m. – 8:30 a.m. Pre-conference breakfast, sponsor table browsing and networking.
8:30 a.m. – 8:40 a.m. Conference opener
- Introduction – Scott LaGanga, Executive Director Partnership for Safe Medicines; Senior Vice President, Public Affairs – Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
8:40 a.m. – 9:10 a.m. Original Research
- Dr. Marv Shepherd, Director, Center for Pharmacoeconomic Studies
College of Pharmacy, University of Texas-Austin - After Counterfeit Avastin – What have we learned and what can be done
Dr. Tim Mackey, Assistant Professor, UCSD School of Medicine
Associate Director, MAS Program in Health Policy and Law
Director, Global Health Policy Institute
9:10 a.m. – 10:25 a.m. Panel 1: The Global Perspective – What are the global issues of counterfeit, substandard and non-FDA approved drugs that impact American patients?
- Moderator: Tom Kubic, President and CEO, Pharmaceutical Security Institute
Panelists:
- Gillian Buckley, Program Officer, Institute of Medicine
- Jim Dahl, Assistant Director of the FDA’s Office of Criminal Investigations (OCI) (retired)
- Samantha Gompel, IPM Communications Manager at the World Customs Organization
- Philip Walsky, Acting Director, FDA-OCI
10:25 a.m. – 10:40 a.m. Networking Break
10:40 a.m. – 11.55 a.m. Panel 2: Patient safety and criminal prosecutions in the U.S.
- Moderator: Linda I. Marks, Senior Litigation Counsel, Consumer Protection Branch, Department of Justice
Panelists:
- Lindsay Androski Kelly, Assistant U.S. Attorney
- Jaime Pena, Assistant U.S. Attorney
- TBD
11:55 a.m. – 12:55 p.m. Networking Lunch
12:55 p.m. – 1:05 p.m. Pre-Panel Presentation (downstairs) PSM India
- Bejon Misra, Founder, Partnership for Safe Medicines India
- Madame LiHong Gu, Partnership for Safe Medicines China
1:05 p.m. – 2:20 p.m. Panel 3: The Impacts of Fake Online Pharmacies on Patient Safety
- Moderator: Special Agent Daniel Burke, Senior Operations Manager in Charge of Cybercrime Investigations for the Office of Criminal Investigations
Panelists:
- Libby Baney, Executive Director, Alliance for Safe Online Pharmacies
- Todd Brown, Executive Director, Massachusetts Independent Pharmacists Association
- Kenneth “Mac” McCall, President, Maine Pharmacy Association
2:20 p.m. – 2:50 p.m. Panel 4: How the Black Market Impacts Patients
- Moderator: Jim Dahl
Panelists:
- Kimberly New, National Association of Drug Diversion Investigators
- Gaurvika Nayyar, Program Manager for Asia at United States Pharmacopeia’s Promoting the Quality of Medicines Program
- Eric Sampson, Advisor to the CDC Foundation
2:50 p.m. – 3:05 p.m. Mid Afternoon Break
3:05 p.m. – 3:35 p.m. Keynote
- Jim Hood, Attorney General, State of Mississippi
3:35 p.m. – 4:15 p.m. Keynote
- Howard Sklamberg, FDA Deputy Commissioner
4:15 p.m. – 4:17 p.m. Closing Remarks, Marv Shepherd
4:17 p.m. – 5:15 p.m. Reception